51品茶 Approved for First Fellowship in Cardiology
Just in time for Valentine's Day, 51品茶's Charles E. Schmidt College of Medicine has received accreditation for its first fellowship in cardiology, which will be based at Delray Medical Center.
51品茶 Approved for Neurology Residency Program
51品茶's Charles E. Schmidt College of Medicine has received approval for a University-sponsored residency program in neurology, in collaboration with Boca Raton Regional Hospital and Delray Medical Center.
Leading Addiction Researcher Joins 51品茶
Lawrence Toll, Ph.D., a renowned scientist whose research focuses on the management of pain and drug addiction through pharmacology and new drug discovery, recently joined 51品茶.
NIH Awards $4 Million to 51品茶 for Prescription Opioid Study
A researcher from the Schmidt College of Medicine is conducting a novel study to figure out if there is a unique genetic signature of patients who are most susceptible to prescription opioid-use disorder.
Randy Blakely and Amy Wright Named as 2017 NAI Fellows
Randy Blakely, Ph.D. and Amy Wright, Ph.D. have been named NAI Fellows.
First-of-its-kind Bioengineered Robotic Hand to Sense Touch
51品茶 has received a $1.3 million NIH grant for a "living" robot with its own nervous system. Researchers are creating a living pathway from the robot's touch sensation to the user's brain to help amputees.
Most Hospice Workers Don't Have an Advance Directive
A new study finds that the majority of hospice providers don't have end-of-life wishes themselves. Procrastination, fear of the subject and costs were reported as the most common barriers.
51品茶 Unveils New Medical Simulation Center
51品茶's Charles E. Schmidt College of Medicine hosted a ribbon-cutting ceremony to observe the official launch of its newly expanded, 15,000-square-foot, state-of-the-art Clinical Skills Simulation Center.
Young-onset Dementia Costs Nearly Twice That of Alzheimer's
The first economic study on frontotemporal degeneration (FTD), the most common dementia for people under age 60, shows that FTD inflicts a much more severe burden on families than Alzheimer's disease.
'Out-of-the-box' Thinking May Build a Better Brain
The "Dementia Prevention Initiative" abandons generalized methods used to research and treat Alzheimer's disease. The secret weapon: a novel "N-of-1 design" that personalizes medicine down to a single patient.